A Clinical Study of 8MW2311 in Subjects With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT05416749 · SUSPENDED
Trial details
- NCT number
- NCT05416749
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-05
- Primary completion
- 2026-03-01
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.